Express Scripts Launches First Digital Health Formulary for Apps & Devices (HIT Consultant):
“Starting in January 2020, Express Scripts Digital Health Formulary will initially include 15 solutions for remote monitoring services and digital therapeutics that aid in the management of eight of the country’s most common chronic conditions: diabetes, prediabetes, hypertension, asthma, pulmonary disease, depression, anxiety, and insomnia … Participating health plans and employers can increase patients’ access to emerging products and technologies simply and affordably and can rest easier with the knowledge that these new tools have been reviewed by a team of experts who will ensure the products work, provide a user-friendly experience and are worth the investment. People who use a program on the Digital Health Formulary also will receive support from Express Scripts specialist pharmacists to ensure the appropriate use of the technology.”
About the Digital Health Formulary:
Express Scripts Makes Digital Health Click (company announcement):
“In May, we announced we were developing the first-ever formulary for digital health. Since then, we have been building this industry changing platform, establishing a four-stage formulary review and selection protocol and reviewing hundreds of submissions from digital health developers … Now, we’ve established the first group of 15 clinically validated programs from leading digital health developers to be included in our first release starting in January 2020. We’ve set the bar high for clinical effectiveness, user experience and financial value for digital health solutions, while also combining coverage into the pharmacy benefit and providing patients with expert support from Express Scripts specialist pharmacists.
The Express Scripts Digital Health Formulary initially includes 15 solutions, including remote monitoring services and digital therapeutics, that aid in the management of eight of the country’s most common chronic conditions: diabetes, prediabetes, hypertension, asthma, pulmonary disease, depression, anxiety and insomnia.” — for the last three conditions, the formulary includes Learn to Live and SilverCloud Health cognitive behavioral therapy.
News in Context:
- The National Academy of Medicine (NAM) shares discussion paper to help empower 8 billion minds
- A call to action: We need the right incentives to guide ethical innovation in neurotech and healthcare
- Bayer to support 11 digital health startups, 5 of which are developing behavioral/ cognitive/ mental health solutions